These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Gene therapy: research in public. Culliton BJ Science; 1985 Feb; 227(4686):493-6. PubMed ID: 3880924 [TBL] [Abstract][Full Text] [Related]
10. Public regulation of recombinant dna gene therapy. McGarity TO; Shapiro SA J Leg Med; 1982 Jun; 3(2):185-210. PubMed ID: 6981676 [No Abstract] [Full Text] [Related]
11. National Institutes of Health. Points to consider in the design and submission of human somatic-cell gene therapy protocols. Human Gene Therapy Subcommittee, NIH Recombinant DNA Advisory Committee. Adopted September 29, 1986. Recomb DNA Tech Bull; 1986 Dec; 9(4):221-42. PubMed ID: 3469693 [No Abstract] [Full Text] [Related]
12. Human gene therapy and congress. Cook-Deegan RM Hum Gene Ther; 1990; 1(2):163-70. PubMed ID: 2078577 [TBL] [Abstract][Full Text] [Related]
13. Public oversight is necessary if human gene therapy is to progress. Zallen DT Hum Gene Ther; 1996 May; 7(7):795-7. PubMed ID: 8860831 [No Abstract] [Full Text] [Related]
14. NIH guidelines for research involving recombinant DNA molecules. Wilson DJ Account Res; 1993; 3(2-3):177-85. PubMed ID: 11652293 [No Abstract] [Full Text] [Related]
17. Points to consider in the design and submission of human somatic cell gene therapy protocols. Recomb DNA Tech Bull; 1985 Dec; 8(4):181-6. PubMed ID: 3912845 [No Abstract] [Full Text] [Related]